【中国生物科技领域重大突破！】周二，港股生物医药股集体爆发，恒生生物科技指数一度大涨超 4%。三生制药早盘暴涨 40%，创历史新高，荣昌生物大涨超 16%，瀚森制药、石药集团等大幅走高。三生制药与辉瑞达成合作，前者将获 12.5 亿美元预付款，潜在里程碑付款高达 48 亿美元，还有产品净销售额的阶梯式双位数百分比特许权使用费。分析师称此为中国生物科技公司最大对外授权交易，市场反应显示投资者认可行业...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.